Position in BCAB
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,725
-$193,242 QoQ
Shares Held
23,142
-93.3% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Derivatives in BCAB
reported options exposure · as of Mar 31, 2026CallValue
$11,302
CallShares
70,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,363,981,840 across 291 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in BCAB
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,302 | 70,200 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $3,725 | 23,142 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $196,967 | 346,774 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $133,731 | 194,377 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $19,814 | 28,800 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $6,789 | 17,144 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,094 | 72,320 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $88,230 | 149,291 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $86,392 | 49,087 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $187,280 | 136,701 | Shares | Defined | 2024-08-15 | |
| 2023-12-31 | $287,816 | 116,999 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $151,350 | 50,450 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $308,636 | 115,163 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $461,191 | 55,902 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $98,290 | 12,765 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $66,635 | 23,381 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $205,155 | 41,031 | Shares | Defined | 2022-05-17 | |
| 2021-09-30 | $236,903 | 8,047 | Shares | Defined | 2021-11-16 | |
| 2021-03-31 | $357,252 | 7,027 | Shares | Defined | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||